Richard Godfrey is Chief Operating Officer, appointed in December 2021. He is responsible for business development, opportunities assessment, project management and corporate affairs.

He brings a wealth of experience from industry, biotech and private equity, most recently as CEO of BerGenBio ASA, an oncology biotech which he led from university spin out to phase III.

Having trained in the UK as a pharmacist, he started his career as a research scientist before assuming positions of increasing responsibility in supply chain, marketing, sales and general management.

He went on to hold executive positions in the UK, the USA and Norway, and was responsible for establishing successful international collaborative R&D projects with academic and commercial partners including Merck, Jansen, UK Research and Innovation (UKRI), as well as with universities in the USA, UK and Europe.

Message Richard

  • Hidden
  • Hidden
  • In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. A backup of your data will be held but only authorised individuals will be able to access your data. If you would like your data to be removed, please email
    Please see our Privacy policy in relation to the personal data you submit to us through this page.
  • This field is for validation purposes and should be left unchanged.
Back to our management team